Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02181218
Title Phase I Study of Romidepsin, Gemcitabine, Oxaliplatin, and Dexamethasone in Patients With Relapsed/Refractory Aggressive Lymphomas
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Washington University School of Medicine
Indications

peripheral T-cell lymphoma

diffuse large B-cell lymphoma

Hodgkin's lymphoma

Therapies

Pegfilgrastim

Romidepsin

Dexamethasone + Gemcitabine + Oxaliplatin

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
University of Chicago Chicago Illinois 60637 United States Details
Washington University School of Medicine Saint Louis Missouri 63110 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field